Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells

We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells.

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Hui, Zhenzhen, Zhang, Xinwei, Ren, Baozhu, Li, Runmei, Ren, Xiubao
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2015
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4681774/
https://ncbi.nlm.nih.gov/pubmed/26734004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2015.00633
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky